Early Detection of Urinary Proteome Markers of BLM-induced Pulmonary Fibrosis in Patients with MOGCT

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900023652

Enrollment

Unknown

Registered

2019-06-05

Start date

2019-06-01

Completion date

Unknown

Last updated

2019-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

malignant ovarian germ cell tumor

Interventions

Case series:?????????

Eligibility

Sex/Gender

Female

Age

1 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Aged 1-40 years; 2. Pathologically confirmed malignant germ cell tumors of the ovary; 3. Chemotherapy regimen containing BLM; 4. Life expectancy exceeds 3 months; 5. Normal blood routine, liver and kidney function and urine routine.

Exclusion criteria

Exclusion criteria: 1. With pulmonary fibrosis already; 2. Unable to complete the follow up; 3. Past history of lung disease treatment; 4. Other malignant tumors in the past five years.

Design outcomes

Primary

Measure	Time frame
urinary proteome;	—

Countries

China

Contacts

Public ContactWang Jinhui

Peking Union Medical College Hospital

wjhpumch@163.com+86 13661286635

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026